
Direxion Daily S&P Biotech Bear 3X Shares (LABD) Price & Chart
LABD ETF Chart & Stats
- Day’s Range
- $7.13 - $8.01
- 52-Week Range
- $5.81 - $33.24
- Previous Close
- $7.81
- Volume
- 19.16M
- Average Volume (3M)
- 20.07M
- AUM
- 66.42M
- NAV
- 7.15
- Expense Ratio
- 1.07%
- Holdings Count
- 3
- Beta
- -3.17
- Inception Date
- May 28, 2015
- Last Dividend Ex-Date
- Sep 22, 2026
- Dividend Yield
- (6.45%)
- Shares Outstanding
- 9,956,480
- Standard Deviation
- N/A
ETF Overview
Direxion Daily S&P Biotech Bear 3X Shares
The Direxion Daily S&P Biotech Bear 3X Shares ETF, with the ticker LABD, is a specialized financial instrument designed for those who seek to capitalize on the short-term market movements within the biotechnology sector, a dynamic niche of the broader health care category. This ETF is a leveraged fund, aiming to deliver three times the inverse of the daily performance of the S&P Biotechnology Select Industry Index. By doing so, LABD provides an aggressive tool for traders looking to bet against the biotech industry's daily fluctuations. Investors interested in this ETF should have a strong appetite for risk and a keen eye on biotech trends, as its leveraged nature means that both potential returns and losses are magnified. Ideal for sophisticated investors with a tactical approach, LABD offers an intriguing avenue to potentially profit from downturns in the biotechnology sector, making it a compelling option for those with a bearish outlook on biotech stocks.
Direxion Daily S&P Biotech Bear 3X Shares (LABD) Fund Flow Chart
LABD ETF FAQ
What was LABD’s price range in the past 12 months?
What is the AUM of LABD?
Does LABD pay dividends?
How many shares outstanding does LABD have?
Top 10 Holdings
| Name | Weight % |
|---|---|
| FTIXXFTIXX | 41.37% |
| DGCXXDGCXX | 9.58% |
| Total | 50.96% |











